topics abla 
LexBlog IP
SEPTEMBER 7, 2023
Topics that will be covered include the 271(e) Safe Harbor, peremptory challenges, labelling and timing considerations, and competitive intelligence. Click here to register for the webinar.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., is a ‘submit[ter]’ of the aBLA within the meaning of 35 U.S.C. §
Expert insights. Personalized for you.
52 
Let's personalize your content